Latest updates for Asgct 2026

Fresh curated links around ASGCT 2026 are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Recent items include:

  • ASGCT CEO David Barrett Previews the Upcoming Conference in Boston
  • ASGCT 2026: AI-Optimized Cas12l Gene Editor Offers Compact Cas9 Alternative
  • ASGCT 2026: Beverly Davidson Offers Vehicle and Route for Huntington’s Disease Gene Therapy

Post angles to try

Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

genengnews.com /3 weeks ago

ASGCT CEO David Barrett Previews the Upcoming Conference in Boston

Before the conference gets underway, GEN spoke with David Barrett, JD, the CEO of ASGCT, to ask his perspective on what attendees should be looking out for, and what he, personally...

Read source
genengnews.com /2 weeks ago

ASGCT 2026: AI-Optimized Cas12l Gene Editor Offers Compact Cas9 Alternative

The CEO of Caszyme, a biotech company in Vilnius, Lithuania, presented details of Cas12l, a novel compact Cas nuclease with a variety of potential research and therapeutic applicat...

Read source
genengnews.com /2 weeks ago

ASGCT 2026: Beverly Davidson Offers Vehicle and Route for Huntington’s Disease Gene Therapy

Beverly Davidson, PhD, chief scientific strategy officer at Children's Hospital of Philadelphia, shares her research including a novel gene therapy approach for Huntington's diseas...

Read source
genengnews.com /2 weeks ago

ASGCT Q1 Landscape Report Paints Positive Picture for Gene and RNA Therapy

The American Society for Gene and Cell Therapy (ASGCT) CEO David Barrett, JD, noted there has been “a nice uptick” in Q1 in start-up funding compared to the same quarter last year,...

Read source
genengnews.com /2 weeks ago

ASGCT 2026: Rare Instance of AAV Integration into Human Genome Linked to Brain Tumor

Researchers at Children's Hospital of Philadelphia uncovered a rare instance of AAV vector integration into the genome of a young patient, resulting in a brain tumor. While the pat...

Read source
genengnews.com /1 month ago

AGBT 2026 Recap: NGS Big Bets and Spatial’s Rising Momentum

For the genomics community February means the season of big announcements as the AGBT meeting—which has earned a reputation for breaking field-shaping news—takes place. The meeting...

Read source
genengnews.com /3 weeks ago

G-Link CAR-T Delivery Platform Showcased at ASGCT

The modular plug-and-play protein adapter developed in collaboration with Menachem Rubenstein, PhD, of the Weizmann Institute allows drug developers to cap and retarget existing le...

Read source
genengnews.com /2 weeks ago

ASGCT President Terry Flotte Touts Rare Disease Initiatives as His Term Ends

Terry Flotte, MD, steps down as ASGCT president at the end of this week. In this exclusive interview, Terry shares the highlights of his tenure, including important initiatives in...

Read source
genengnews.com /1 month ago

AACR 2026: A Video Update from San Diego

From the AACR Annual Meeting in San Diego, Julianna LeMieux and Damian Doherty report on early highlights, including key insights and takeaways from the first few days of the meeti...

Read source
genengnews.com /1 month ago

AACR 2026 Chairs Identify Themes and Highlights from the Conference

Before heading to the AACR meeting in San Diego, program chairs Paul Mischel and Alice Shaw shared insights with GEN on the key themes shaping this year’s program and what excites...

Read source
ipscell.com /1 week ago

FDA’s Megha Kaushal ASGCT talk: PFDD, patient voices, decision-making

I’ve been thinking more about the interplay between patient voices and FDA oversight of emerging cell and gene therapies. How do we find integration and balance here? In line with...

Read source
fiercebiotech.com /1 month ago

Biotech Giants and Investors Gather to Solve the Commercialisation Puzzle This May in Hong Kong

Join global leaders at ASGH 2026 to bridge the gap between lab breakthroughs and market execution while unlocking growth in Asia’s health economy.

Read source
labiotech.eu /1 month ago

AACR 2026: where is cancer therapeutics heading?

AACR 2026 saw thousands gathered in San Diego, California, where major progress in cancer research was revealed. The post AACR 2026: where is cancer therapeutics heading? appeared...

Read source
bioengineer.org /2 weeks ago

City of Hope Researchers to Present Groundbreaking Immunotherapy and Precision Medicine Advances Across Multiple Cancer...

City of Hope’s Cutting-Edge Cancer Research to Dominate ASCO 2026, Setting New Standards in Immunotherapy and Precision Medicine As the oncology world prepares to convene in Chicag...

Read source
aacr.org /1 month ago

Live Updates From the AACR Annual Meeting 2026: Tuesday, April 21

Live updates from the fifth day of the AACR Annual Meeting 2026, including a plenary on early-onset cancers, the final Clinical Trial Plenary, and more. The post Live Updates From...

Read source
aacr.org /1 month ago

Daily Recaps From the AACR Annual Meeting 2026: Wednesday, April 22

A recap of the last day of the AACR Annual Meeting 2026, including plenaries on innovative treatment modalities and overall meeting highlights. The post Daily Recaps From the AACR...

Read source
seekingalpha.com /1 month ago

Assembly Biosciences, Inc. (ASMB) Presents at ESCMID Global 2026 - Slideshow

Read source
genengnews.com /3 weeks ago

ASGCT Honors Mohamed Abou‑el‑Enein as Outstanding New Investigator

USC physician-scientist Mohamed Abou-el-Enein, MD, PhD, earned dual ASGCT honors for work that links high-dimensional CAR T analytics with real-world translation. His measurement-f...

Read source
rna-seqblog.com /1 month ago

Wobble Genomics to present novel mRNA sequencing research at AACR 2026

RNA sequencing of full-length mRNA from blood supports liquid biopsy approaches for selecting antibody-drug conjugate therapies in breast cancer, improving precision treatment deci...

Read source
biopharmadive.com /1 month ago

AACR 2026: Revolution’s next prospect, Merck’s reveal and a lung cancer battle

Featured at this year’s meeting on early cancer research were results from an immunotherapy Merck acquired in 2024 and several targeted medicines for lung tumors.

Read source
rna-seqblog.com /4 weeks ago

RNA Horizons – Sept 16-18, 2026 – Munich, Germany

RNA Horizons 2026 will highlight advances in RNA therapeutics, biomarker discovery, and delivery technologies, bringing together experts to explore innovation across cancer, rare d...

Read source
jdsupra.com /1 month ago

Life Science Update | March 2026

Advances in AI and genomic analysis will allow medical providers to tailor treatment for individual patients at the genome level, but challenges exist for protecting AI-assisted in...

Read source
bioengineer.org /1 month ago

Dana-Farber Scientists to Showcase Over 50 Research Studies at AACR Annual Meeting 2026

Dana-Farber Cancer Institute researchers are set to unveil over 50 groundbreaking studies at the upcoming American Association for Cancer Research (AACR) Annual Meeting in 2026, he...

Read source
genengnews.com /3 weeks ago

Next Gen Leadership Awards Presented at the AGBT Agricultural Meeting

The AGBT Agricultural Meeting was held last month in Phoenix, Arizona. During the meeting, the recipients of the Next Gen Leadership Awards were announced, recognizing outstanding...

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.

Sources covering Asgct 2026

bioengineer.org

Recent coverage from public sources
Public source

feeds.feedburner.com

Recent coverage from public sources
Public source

ipscell.com

Recent coverage from public sources
Public source

seekingalpha.com

Recent coverage from public sources
Public source

aacr.org

Recent coverage from public sources
Public source

biopharmadive.com

Recent coverage from public sources
Public source